학술논문
Outcome and Prognostic Factors of COVID-19 Infection in Swiss Cancer Patients: Final Results of SAKK 80/20 (CaSA).
Document Type
Article
Author
Joerger, Markus; Metaxas, Yannis; Zaman, Khalil; Michielin, Olivier; Mach, Nicolas; Bettini, Adrienne; Schmitt, Andreas M.; Cantoni, Nathan; Caspar, Clemens B.; Stettler, Sonja; Malval, Roma; Pless, Miklos; Britschgi, Christian; Renner, Christoph; Koeberle, Dieter; Schulz, Jessica D.; Kopp, Christoph; Hayoz, Stefanie; Stathis, Anastasios; von Moos, Roger
Source
Subject
*EVALUATION of medical care
*REPORTING of diseases
*INTENSIVE care units
*COVID-19
*CANCER patients
*RISK assessment
*HOSPITAL care
*OXYGEN therapy
*
*
*
*
*
*
*
Language
ISSN
2072-6694
Abstract
Simple Summary: The characterization of clinical outcomes and prognostic factors in COVID-19-infected cancer patients is important for health care authorities, policy makers and oncologists. We collected extensive data on COVID-19-infected cancer patients from 1 March 2020 over a one-year period. Among 455 patients included, death from COVID-19 infection occurred in 98 patients, resulting in a mortality rate of 21.5%. Age ≥ 65 years, non-curative disease, intensive care unit admission and oxygen requirement were particular and independent negative prognostic factors for death from COVID-19. COVID-19 severity and mortality in cancer patients remained high in a country (Switzerland) with a decentralized, high-quality, universal-acess health care system. Purpose: These are the final results of a national registry on cancer patients with COVID-19 in Switzerland. Methods: We collected data on symptomatic COVID-19-infected cancer patients from 23 Swiss sites over a one-year period starting on 1 March 2020. The main objective was to assess the outcome (i.e., mortality, rate of hospitalization, ICU admission) of COVID-19 infection in cancer patients; the main secondary objective was to define prognostic factors. Results: From 455 patients included, 205 patients (45%) had non-curative disease, 241 patients (53%) were hospitalized for COVID-19, 213 (47%) required oxygen, 43 (9%) invasive ventilation and 62 (14%) were admitted to the ICU. Death from COVID-19 infection occurred in 98 patients, resulting in a mortality rate of 21.5%. Age ≥65 years versus <65 years (OR 3.14, p = 0.003), non-curative versus curative disease (OR 2.42, p = 0.012), ICU admission (OR 4.45, p < 0.001) and oxygen requirement (OR 20.28, p < 0.001) were independently associated with increased mortality. Conclusions: We confirmed high COVID-19 severity and mortality in real-world cancer patients during the first and second wave of the pandemic in a country with a decentralized, high-quality, universal-access health care system. COVID-19-associated mortality was particularly high for those of older age in a non-curative disease setting, requiring oxygen or ICU care. [ABSTRACT FROM AUTHOR]